Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice

NeuroReport

Volumn 20, Issue 12, 2009, Pages 1087-1092

  Arendash, Gary W ^a,b   Cox, April A ^b   Mori, Takashi ^e   Cracchiolo, Jennifer R ^b   Hensley, Kenneth L ^c   Roberts II, L Jackson ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Cognitive impairment; Hyperoxia; Oxidative stress; Oxygen; Transgenic mice

Indexed keywords

OXYGEN; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPOSURE; HYPEROXIA; LIPID PEROXIDATION; MAJOR SURGERY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; LEARNING DISORDERS; LIPID PEROXIDATION; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; MICE, TRANSGENIC; OXYGEN; RECEPTORS, CELL SURFACE; REVERSAL LEARNING; SWIMMING; SYNAPTOPHYSIN;

EID: 68249113675     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32832e6459     Document Type: Article

References (20)

1. Price C, Garvan C, Monk T. Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology 2008; 108:8-17
2. Selnes O, McMcKhann G. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol 2005; 57:615-621. (Pubitemid 40628849)
3. Monk T, Weldon B, Garvan C, Dede D, van der Aa M, Heilman K, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108:18-30.
4. Xie Z, Dong Y, Maeda U, Moir R, Inouye S, Culley D, et al. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Geronto 2006; 61A:1300-1306. (Pubitemid 46147786)
5. Mandal P, Williams J, Mandal R. Molecular understanding of Aβ peptide interaction with isoflurane, propofol, and thiopental: NMR spectroscopic study. Biochemistry 2007; 46:762-771. (Pubitemid 46133592)
6. Zhilyaev S, Moskvin A, Platonova T, Gutsaeva D, Churilina I, Demchenko I. Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions. Neurosci Behav Physiol 2003; 33:783-787. (Pubitemid 38129931)
7. Arendash G, Su G, Crawford F, Bjugstad K, Mullan M. Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. Neurosci Lett 1999; 268:17-20. (Pubitemid 29292534)
8. Onodera K, Omoi N, Hayasaka T, Shinkai T, Suzuki S, Abe K, et al. Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia. Free Radic Res 2003; 37:367-372. (Pubitemid 36240399)
9. Urano S, Asai Y, Makabe S, Matsuo M, Izumiyama N, Ohtsubo K, Endo T. Oxidative injury of synapse and alteration of antioxidative defense systems in rats and its prevention by vitamin E. Eur J Biochem 1997; 245:64-70. (Pubitemid 27142264)
10. Gordon-Majszak W, Gajkowska B. Biochemical and morphological changes in rat brain synaptosomes after exposure to normobaric, hyperoxia in vivo. Exp Toxicol Pathol 1992; 44:96-101.
11. Newman M, Kirchner J, Jones R, Mark D, Reves J, Blumenthal J. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344:395-402. (Pubitemid 32128671)
12. Arendash G, Schleif W, Rezai-Zadeh K, Jackson E, Zacharia L, Cracchiolo J, et al. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 2006; 142:941-952. (Pubitemid 44740473)
13. Cracchiolo J, Mori T, Nazian S, Tan J, Potter H, Arendash G. Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 2007; 88:277-294. (Pubitemid 47321221)
14. Costa D, Cracchiolo J, Bachstetter A, Hughes T, Bales K, Paul S, et al. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging 2007; 28:831-844. (Pubitemid 46613825)
15. Fessel J, Hulette C, Powell S, Roberts LJ II, Zhang J. Isofurans, but not F2-isoprostanes, are increased in substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. J Neurochem 2003; 85:645-650. (Pubitemid 36531927)
16. King D, Arendash G. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res 2002; 926:58-68. (Pubitemid 34117590)
17. Fessel J, Porter N, Moore K, Sheller J, Roberts L. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A 2002; 99:16713-16718. (Pubitemid 36034038)
18. Paris D, Quadros A, Humphrey J, Patel N, Crescentini R, Crawford F, et al. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice. Brain Res 2004; 999:53-61. (Pubitemid 38121450)
19. Iadelcola C. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia. Cell Mol Neurobiol 2003; 4-5:681-689.
20. Chernov V, Efimova N, Efimova I, Akhmedov S, Lishmanov Y. Short-term and long-term cognitive function and cerebral perfusion in off-pump and on-pump coronary artery bypass patients. Eur J Cardiothoracic Surg 2006; 29:74-81. (Pubitemid 41831353)